U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

How pharmaceutical tariffs could reshape drug pricing, supply chains and domestic production in the United States, according ...

America's pharmaceutical sector is facing huge uncertainty from the tariff threat, cuts at the US Department of Health, and a ...

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

Trump and his aides have repeatedly shifted their stance on tariffs in the weeks since the president’s “Liberation Day” ...

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...

US President Donald Trump on May 23 threatened to impose a 50 percent tariff on all imports from the European Union.

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

U.S. dependency on China for critical goods like rare earths and pharmaceuticals poses risks. Trump's strategies aim to ...

The rulings against the levies in two federal courts – the U.S. Court of International Trade and the U.S. District Court in ...

Volley after volley of new tariffs from U.S. President Donald Trump have plunged the country into trade wars abroad, creating ...

The U.S. federal court ruling that President Trump had overstepped his authority on imposing tariffs marked a clear setback ...